147 related articles for article (PubMed ID: 35605053)
1. FDG PET/CT in Eosinophilic Solid and Cystic Renal Cell Carcinoma With Lung Metastases.
Zhang J; Dong A; Wang Y
Clin Nucl Med; 2022 Oct; 47(10):921-922. PubMed ID: 35605053
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT and 99mTc-MIBI SPECT/CT Findings in a Patient With Eosinophilic Solid and Cystic Renal Cell Carcinoma.
Tong Z; Shen Q; Sun H; Zhang J; Fan Y
Clin Nucl Med; 2022 May; 47(5):464-466. PubMed ID: 35085167
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT in a Case With Cellular Schwannoma of the Kidney.
Yu Z; Zhang J; Dong A; Zhu Y
Clin Nucl Med; 2022 Nov; 47(11):996-997. PubMed ID: 35619199
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
[TBL] [Abstract][Full Text] [Related]
7. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
8. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
10. Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison
Kitajima K; Yamamoto S; Kawanaka Y; Katsuura T; Fujita M; Nakanishi Y; Yamada Y; Hashimoto T; Suzuki T; Go S; Kanematsu A; Nojima M; Yamakado K
Jpn J Radiol; 2019 Feb; 37(2):165-177. PubMed ID: 30377936
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder Metastasis From Renal Cell Carcinoma Revealed With 18 F-FDG PET/CT.
Baloğlu MC; Yahşi S; Erol Fenercioğlu Ö; Çermik TF; Ergül N
Clin Nucl Med; 2022 Sep; 47(9):e587-e588. PubMed ID: 35452011
[TBL] [Abstract][Full Text] [Related]
13. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT in Solitary Isolated Renal Metastasis From Squamous Cell Lung Cancer.
Zhang J; Dong A; Wang Y
Clin Nucl Med; 2024 Feb; 49(2):e50-e51. PubMed ID: 38048520
[TBL] [Abstract][Full Text] [Related]
15. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Xie F; Fu L; Zhou W
Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
[TBL] [Abstract][Full Text] [Related]
16. [
Airò Farulla LS; Travaini LL; Cuomo M; Galetta D; Mattana F; Frassoni S; Buonsanti G; Muraglia L; Zuccotti GA; Bagnardi V; Spaggiari L; Ceci F
Tomography; 2023 Feb; 9(1):387-397. PubMed ID: 36828383
[TBL] [Abstract][Full Text] [Related]
17. Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
Kayani I; Avril N; Bomanji J; Chowdhury S; Rockall A; Sahdev A; Nathan P; Wilson P; Shamash J; Sharpe K; Lim L; Dickson J; Ell P; Reynolds A; Powles T
Clin Cancer Res; 2011 Sep; 17(18):6021-8. PubMed ID: 21742806
[TBL] [Abstract][Full Text] [Related]
18. Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography--a preliminary report.
Chang CH; Shiau YC; Shen YY; Kao A; Lin CC; Lee CC
Urol Int; 2003; 71(3):306-9. PubMed ID: 14512653
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI SPECT/CT and FDG PET/CT in Isolated Bilateral Renal Metastases From Adenoid Cystic Carcinoma of the Maxilla.
Zhao Q; Dong A; Ye H; Zuo C
Clin Nucl Med; 2022 Feb; 47(2):e205-e207. PubMed ID: 35006121
[TBL] [Abstract][Full Text] [Related]
20. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]